U.S. Specialized REITs Stock News

Stifel Financial has delivered a powerful run for long term holders, yet the recent pullback leaves a straightforward question for anyone looking at the ticker today. Is the current share price properly aligned with what the business is earning? Over the past 3 years the stock has gained about 91.1%, which now puts the spotlight on whether that climb is still supported by the company’s profit engine. Recent senior hires in venture banking and European leveraged finance may support...

International Business Machines (NYSE: IBM) agreed to collaborate with CUBE to integrate regulatory intelligence into watsonx.governance. The tie up embeds CUBE's automated global regulatory horizon scanning directly into IBM's AI governance offering for enterprise clients. The integration targets risk and compliance teams that need continuous updates on AI related regulatory changes across multiple jurisdictions. IBM's CUBE powered regulatory intelligence push is one step in a wider story...

Trade friction between the U.S. and Canada has turned household appliances into collateral, with 50% tariffs on key goods and sharp aluminum cost inflation reshaping who wins and who struggles. Investors watching this cross-border standoff can find both risk and potential opportunity as cost pressures and supply chains shift. This article breaks down three U.S.-focused consumer durables stocks exposed to the news and explains how the story could matter for your portfolio. The three stocks...

Ford Motor has been rolling out an updated 2027 F-150 lineup with fresh styling, new in-cabin tech, and lower prices on several premium trims, while expanding Ford Pro software, telematics, and aftermarket services that already reach 1.6 million paid subscribers and roughly 530,000 active BlueCruise users. The push toward recurring digital revenue in Ford Pro, extended range electric trucks, and proprietary electrical architecture shifts Ford Motor’s focus from one off vehicle sales toward...

Elevance Health has had a solid run over the past year, and the stock is now trading with recent news about its earnings outlook fresh in investors' minds. The core question is whether the current share price is warranted by the healthcare insurer's ability to keep converting its profit story into sustainable earnings per share. The stock has gained 33.6% over the past 12 months, which puts more weight on whether that move is supported by the underlying earnings power of the...

Boston Scientific has seen a sharp reset in its share price over the past year, which puts a fresh spotlight on whether today's valuation is still supported by the cash the business is expected to generate. After a period of weaker returns, the key issue for investors is how that market reaction lines up with the company’s underlying cash flow profile. The share price has fallen 55.7% over the past year, which puts a lot of weight on whether the current market value still lines up with...

iQIYI (IQ) has put its AI ambitions front and center with the Global AI Creator Challenge on its NadouPro platform, which is built around Alibaba's Wan3.0 model for professional-grade video production. Despite the AI Creator Challenge giving iQIYI fresh narrative momentum, the stock has been under pressure. The share price is down 50.3% year to date and the 1-year total shareholder return has declined 61.2%, while the 3-year and 5-year total shareholder returns are also sharply weaker. Spot...

What the new Lakeside Bluffs launch means for KB Home stock KB Home (KBH) just opened Lakeside Bluffs in Lake Stevens, Washington, a new ENERGY STAR focused townhome community that gives investors a fresh data point on the builder's product mix and regional footprint. Recent trading tells a different story to KB Home’s new project pipeline. The share price has fallen 16.5% over the past month and is down 17.4% year to date, while the 5 year total shareholder return of 24.0% shows that longer...

Cheesecake Factory (CAKE) drew fresh attention after issuing 2026 guidance that points to about US$4b in total revenue and an updated net income margin target of roughly 5.4%. Recent trading reflects that new guidance. Cheesecake Factory’s share price is up 25.0% over 90 days and 82.8% year to date, while the 1-year total shareholder return of 80.1% and 3-year total shareholder return above 2.5x suggest that momentum has been strong even after a softer 7-day and 30-day share price...

Nscale’s push for a US listing at up to a $35b valuation, backed by Nvidia and anchored by long-term AI data centre contracts, has put a fresh spotlight on who really supplies the plumbing for AI. Capital is suddenly hunting for the next critical picks and shovels. This article examines three US and UK stocks from the AI data centre and cloud theme that could be positively exposed to this news-driven shift. The three stocks covered below are just a small sample of this theme. The full screen...

Blue Bird (BLBD) is in focus after investors revisited the school bus maker's fundamentals, including average unit sales growth of 9.2% over two years and an increased free cash flow margin. Recent trading has cooled after a strong run, with Blue Bird's share price falling 18.3% over the past 90 days but still delivering a 29.2% year to date share price return and a 3 year total shareholder return of over 200%. This suggests earlier optimism has been tempered as investors reassess growth...

Invesco (NYSE: IVZ) has partnered with GMH Communities to buy student housing assets near Purdue University. The acquired properties sit close to Purdue's main campus in West Lafayette, Indiana, a large public university in the US. The transaction adds to Invesco Real Estate's student housing holdings as the firm builds out its alternative property portfolio. This Purdue student housing deal only captures one piece of what is changing for Invesco Real Estate today. Our analysis turns up 2...

Twist Bioscience has seen its share price move sharply in recent years, which puts the spotlight squarely on one question for investors who care about cash flows. Is the current valuation supported by what this business is expected to generate in actual dollars over time, or is the market getting ahead of itself? Over the past 3 years, Twist Bioscience has delivered a share price return of about 7x. This raises the stakes on whether its future cash flows can underpin that kind of move. The...

Watts Water Technologies has delivered a strong multi year share price run, so the recent pullback raises a simple question for you as an investor. Are the cash flows behind the business enough to support where the stock trades today? Over the past 5 years, the stock has gained 113.6%, which puts a lot of weight on whether its current cash generation can support that kind of market value. Recent record sales, alongside slipping operating margins, suggest future cash flow may depend less on...

United Rentals recently told investors that construction equipment rental demand has exceeded its own expectations, helped by a strong pipeline of large projects and continued momentum in specialty rentals, which supported a guidance increase in July despite higher diesel costs. Management also highlighted heavier use of technology and AI across operations and customer service, signaling a push to squeeze more productivity and service quality from the existing rental fleet rather than...

Iovance Biotherapeutics (IOVA) is back in focus after reporting record second quarter revenue near US$100 million with a 56% margin, along with wider access to its TIL platform and an expanding solid tumor pipeline. The strong quarterly update has arrived alongside a sharp rebound in Iovance Biotherapeutics’ share price, with a 7-day share price return of 19.19% and a 90-day move of 162.15%. This has contributed to a year-to-date share price return of 306.75% and a 1-year total shareholder...

Plug Power featured as a key technology provider in a multibillion dollar sustainable aviation fuel project in Uzbekistan and recently presented at the Midwest NDR conference, giving investors fresh detail on its operations and financing plans. The Uzbekistan project, which could use up to 2.4 GW of Plug Power GenEco PEM electrolyzers, highlights the company’s focus on large, capital intensive clean hydrogen deployments, alongside efforts to refresh GenDrive units and pursue asset...

Redwire (RDW) just delivered a strong jolt of information for investors, with Q2 revenue and EBITDA beating expectations and management lifting full year guidance as analysts reassessed the stock’s cash flow potential. That upbeat Q2 message is landing against a mixed tape for Redwire, with the share price down 7.01% over the last day and 25.16% lower across 90 days, yet still showing an 18.94% year to date share price gain and a 35.09% 1 year total shareholder return that may indicate...

Vera Therapeutics reported that TRUTAKNA met all prespecified endpoints in the final Phase III ORIGIN 3 trial in adults with primary IgA nephropathy, with kidney function data characterized as strong, a safety profile generally comparable to placebo, and plans to seek full FDA approval through a supplemental BLA in late 2026. The therapy’s self-administered weekly autoinjector format, combined with early commercial momentum from more than 350 patient start forms, points to an execution focus...

Telephone and Data Systems (TDS) has been drawing fresh attention after recent trading left the stock around $35.90, with returns mixed across the past week, month, and past 3 months. Over the past year, the Telephone and Data Systems share price has moved through a mix of short bursts and pullbacks. The 30-day share price return of 3.55% contrasts with a year-to-date share price decline of 12.55%, while the 3-year total shareholder return of 107.61% and 5-year total shareholder return of...

Blackbaud shares have fallen back, with the stock closing at US$42.85 and posting a series of declines in recent periods. This puts fresh focus on whether that valuation is still supported by the company’s earnings power. After a run of negative returns, the key issue for investors is whether the current price properly reflects what the business is earning today. Over the past 5 years the share price has fallen 40.9%, which raises the question of whether the market is reassessing what...

Eli Lilly has turned into one of the most closely watched stocks in global healthcare, and with that attention comes a simple question for investors. At around US$1,152.93 per share, is the current price in line with the cash flows that Lilly can plausibly generate over time? Over the past 5 years, Eli Lilly has delivered a very large total return of about 4.2x, which puts a lot of weight on whether its cash flows can keep supporting such a re-rating. Recent approvals and upgrades around...

Archer Aviation has seen its share price fall sharply over the past year, which puts an uncomfortable spotlight on whether the current US$5.26 level still lines up with the value on its balance sheet. For anyone watching the electric air taxi space, the question now is how much of Archer Aviation's future story is already baked into a stock that has recently been heading lower. Over the past year the share price has declined 46.7%, which raises the question of whether the market is now...

Fortinet has seen its share price climb sharply in recent years, which puts fresh attention on whether the cash it is expected to generate really supports that kind of move. With the stock recently closing at US$169.84, the key issue is how that market value lines up against what the company's cash flows suggest it might be worth. Over the past 3 years, Fortinet has delivered a 191.6% share price return, which puts a lot of weight on the question of whether its cash generation can keep...